| Home Market Dynamics Macro Trends Sector Trends Company Insights AI Investing Strategies Sign Up Login |
Sector: Health Care
| AbbVie is actively advancing its product development efforts, emphasizing a strong pipeline with new drugs that transition from older revenue sources. The company sees substantial growth potential, particularly from products like Skyrizi and Rinvoq, which are expected to drive significant revenue increases. However, challenges in their product pipeline remain a concern, highlighting the need for continued innovation and effective management of development obstacles. |
| The price action of ABBVIE INC (ABBV) is impacted by broad market risk appetite, sector price trend, company-specific performance and market structure. The trend sentiment at 1.7 is very bullish. The market sentiment at 0.9 is bullish. Trend sentiment measures the current trend of the stock price, and market sentiment reflects what market participants collectively think where the price will move next. ABBV is likely to move up since both trend sentiment and market sentiment are positive. The positive sentiment force for sector is at 1.2, and the negative at -0.3 on 2026-10-15. The forces of Sentiment towards Fundamentals (2.4), Stock Price Trend (1.7), Option Sentiment (1.5), Sector Price Trend (1.3), and Valuation Sentiment (1.2) will drive up the price. The forces of Market Risk Appetite (-0.9), and Price Level Sentiment (-1) will drive down the price. The sentiment for Sector Price Trend is calculated based on the price trend of related sector ETF. The sentiment for Option Speculation is calculated from put/call ratio. The Risk Appetite is calculated from Bitcoin price trend. Price Level sentiment is positive when oversold, and negative when overbought. Valuation Sentiment, and Sentimentals towards Fundamentals are extracted from headlines and market commentary. All sentiment scores are normalized on a -10 - +10 scale. The price level reaches 100 at Bollinger upper band, and zero at lower band. |
Sign up to reveice notifications on Market Movers
| ABBV | ||||||||||||||||
| Date | Attention | Price | StdDev | Price Level | RSI | Hourly RSI | Change | 10 Day Trend | Trend Sentiment | Hourly Trend Sentiment | Hourly StdDev | Market Sentiment | Action | P | Fund. | News Sentiment |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-10-15 | 0%(0%) | 283.27 | 2.5% | 101 | 71 | 52 | -0.09% | 0.88% | 1.7 | -0.4 | 1.6% | 0.9 | Wait | 50% | 2.4 | 6 |
| 2026-10-14 | 0%(0%) | 283.52 | 2.23% | 112 | 70 | 58 | 3.36% | 0.78% | 1.7 | 0.4 | 1.1% | 1.4 | Long | 70% | 2.9 | -1 |
| 2026-10-13 | 0%(0%) | 274.31 | 1.93% | 85 | 62 | 44 | -2.39% | 0.41% | 0.9 | -0.7 | 0.8% | 1 | Wait | 50% | 3.8 | -1 |
| 2026-10-12 | 0%(0%) | 281.04 | 1.8% | 123 | 76 | 78 | 1.66% | 0.56% | 1.6 | 0.5 | 1.2% | 1.1 | Long | 70% | 4.2 | -1 |
| 2026-10-11 | 0%(0%) | 1.4 | 0.5 | 1.3 | 4.9 | -1 | ||||||||||
| 2026-10-10 | 0%(0%) | 1.4 | 0.5 | 1.1 | 4.8 | -1 | ||||||||||
| 2026-10-09 | 0%(0%) | 276.45 | 1.4% | 122 | 72 | 83 | 1.46% | 0.45% | 1.4 | 0.3 | 1.2% | 1.1 | Wait | 50% | 4.6 | -1 |
| 2026-10-08 | 0%(0%) | 272.46 | 1.23% | 111 | 68 | 50 | 0.41% | 0.3% | 1.1 | 0.4 | 1% | 0.9 | Wait | 50% | 4.6 | -1 |
| 2026-10-07 | 0%(0%) | 271.35 | 1.25% | 108 | 66 | 76 | 1.71% | 0.23% | 1 | 0.2 | 1.4% | 1 | Wait | 50% | 4.1 | -1 |
| 2026-10-06 | 0%(0%) | 266.79 | 1.46% | 78 | 61 | 63 | 0.41% | 0.04% | 0.5 | 0.2 | 0.8% | 1.1 | Long | 55% | 4.2 | -1 |
| Wait is the preferred trading strategy with 50% chance of being right. Wait action is recommended in three scenarios with either high uncertainty or high risk: 1. The trend sentiment and market sentiment are at the opposite directions. 2. Both trend sentiment and market sentiment are positive, but the price level is elevated. 3. Both trend sentiment and market sentiment are negative, but the price level is depressed. In an uptrend, as an investor, you may want to wait for the pullback to open long position. In a downtrend, the price will likely rebound after huge decline. As an investor, you may want to wait for the rebound to exit long position. | ||||||||||||||||
| Market sentiment will accelerate the current trend when both trend sentiment and market sentiment are at the same direction. Market sentiment will generate volatility when it's at the opposite direction of the trend sentiment. News sentiment measures the daily emotion of the market. News sentiment may impact the daily price change while market sentiment is a more stable and consistent moving force. | ||||||||||||||||
| Analysis | ||
| ● AbbVie Inc. (ABBV) – Equity Research Report Sun. Mar 1, 2026 | ||
| 2026-10-15 17:01:38 Earnings outlook is improving as AbbVie's newer drugs are anticipated to offset previous revenue declines. |
| 2026-10-15 17:01:38 AbbVie's development of newer drugs is a sign of strong product pipeline transitioning away from older revenue sources. |
| 2026-10-15 17:01:38 Reduction of positions by wealth advisors indicates strategic adjustments in investments in AbbVie. |
| 2026-10-15 17:01:38 Comparison between AbbVie and Pfizer indicates competitive dynamics in the healthcare sector, with AbbVie potentially thriving post-Humira. |
| 2026-10-15 17:01:38 Recent stock performance of AbbVie shows slight fluctuations and interests from investors in both buying and selling. |
| 2026-10-15 15:46:55 The surge in pharmaceutical stocks suggests a strategic investment environment, where more resources are being directed towards healthcare companies. |
| 2026-10-15 15:46:55 The article reflects a broader industry trend where investors are moving towards pharmaceutical stocks amidst a tech selloff, signaling a preference for safer investments. |
| 2026-10-15 15:46:55 The article highlights the impressive stock performance of major pharmaceutical companies, indicating a shift in investor confidence and preference. |
| 2026-10-15 11:47:28 The ongoing struggles and strategies of AbbVie and Pfizer reflect the competitive landscape within the healthcare industry. |
| 2026-10-15 11:47:28 Pfizer's efforts to rebuild its pipeline around new drugs highlight a strategic focus on future earnings. |
| 2026-10-15 11:47:28 Both AbbVie and Pfizer are focused on expanding their product lines, indicating a proactive approach to market needs. |
| 2026-10-15 11:47:28 The positive outlook for AbbVie with drugs like Skyrizi and Rinvoq suggests strong market performance potential. |